ArticleScientific reports2025
Classification of diaphyseal tumors based on residual medullary cavity length for prosthetic reconstruction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diaphyseal prosthetic reconstruction for bone tumors continues to face challenges with failures due to the lack of evidence-based classification systems. This study aimed to develop and validate a novel classification framework to optimize reconstruction strategies through a retrospective analysis of 112 patients undergoing diaphyseal prosthetic reconstruction between 2010-2021. Diaphyseal tumors were classified into five types according to anatomical location and residual medullary cavity length, with each category corresponding to a tailored prosthetic reconstruction strategy. Clinical outcomes demonstrated a mean Musculoskeletal Tumor Society score of 24.3 ± 3.3 with comparable functional outcomes across classification types. The overall complication rate was 16.1% (18/112), primarily involving aseptic loosening (ASL, 8%) and structural failures (3.6%), with a reoperation rate of 6.3% (7/112). Notably, Type I reconstructions using standard stems without plates showed the highest complication rate (21%), while Type IIIa reconstructions exhibited no complications. Competing risk model analysis showed that cumulative mortality rates at 0.5, 1, 3, 5, and 8 years were 6.4%, 17.4%, 54.4%, 59.1%, and 66.5%, respectively, while cumulative complication rates were 2.7%, 6.5%, 12.5%, 19.4%, and 22.5%, respectively. These findings establish diaphyseal prostheses as effective solutions for intercalary defect reconstruction, emphasizing their role in facilitating early weight-bearing and functional recovery. The novel classification system for diaphyseal tumors provides valuable guidance for the design and application of prosthetic reconstructions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.